ORCHEZ
Live / Applied — Fourth extension granted (statement of use) (as of 02 Mar 2026)
What this means for you
Not registered yet, but its 17 May 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90715578
- Mark type
- Stylized text
- Filed
- 17 May 2021
- Published for opposition
- 12 Jul 2022
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Owner
- Teva Pharmaceuticals USA, Inc., Parsippany, NJ, US
- Teva Pharmaceuticals USA, Inc., Parsippany, NJ, US
Prosecution history
- 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2026 — SOU EXTENSION 4 GRANTED
- 22 Jan 2026 — SOU EXTENSION 4 FILED
- 23 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 21 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jan 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Jan 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Jun 2025 — NEW NOA TO ISSUE
- 26 Jun 2025 — NOTICE OF ALLOWANCE CANCELLED
- 26 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Oct 2024 — NOTICE OF REVIVAL - E-MAILED
- 15 Oct 2024 — PETITION TO REVIVE-GRANTED